{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:41:03Z","timestamp":1789756863021,"version":"4.0.1"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Purpose of review: New daily persistent headache (NDPH) is a primary headache disorder characterized by the sudden onset of continuous pain and its intractability to treatment. It is more prevalent in the pediatric population than the adult population, but remains understudied and underdiagnosed. The purpose of the current article is to provide a current overview of new daily persistent headache in the pediatric and adolescent population, including history, pathophysiology, clinical findings, current and emerging treatment options, and the results of recent studies and meta-analyses. Recent findings: Despite recent studies and meta-analyses showing significant phenotypic overlap between chronic migraine and NDPH in the pediatric population, multiple recent studies have come to conflicting conclusions about the overlap of medication overuse in headache and pediatric NDPH. Recent studies reveal alterations in neuroimaging, particularly in functional connectivity, in patients with NDPH. Patients frequently remain treatment-refractory even to medications that have historically proven helpful in this population; however, new treatment options, including calcitonin gene-related peptide (CGRP) monoclonal antibodies, may be more effective. Summary: NPDH remains a perplexing and difficult-to-manage condition for both children and adults. Despite a higher prevalence in the pediatric population, there are relatively few studies to guide the evaluation and treatment of NDPH in pediatric and adolescent patients. Early treatment, both pharmacological and non-pharmacological, should be employed to reduce disability. Overall, further studies are needed to better understand pathogenesis and to identify more effective therapeutic strategies, both pharmacological and non-pharmacological.<\/jats:p>","DOI":"10.3390\/life14060724","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:08:38Z","timestamp":1717409318000},"page":"724","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Daily Persistent Headache in the Pediatric and Adolescent Population: An Updated Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Paige","family":"Kalika","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurology, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-252X","authenticated-orcid":false,"given":"Teshamae S.","family":"Monteith","sequence":"additional","affiliation":[{"name":"Division of Headache Medicine, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/head.13103","article-title":"New Daily Persistent Headache: Historical Review and an Interview with Dr. Walter Vanast","volume":"57","author":"Robbins","year":"2017","journal-title":"Headache"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11910-010-0097-3","article-title":"New daily persistent headache in children and adolescents","volume":"10","author":"Baron","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-2982.2008.01647.x","article-title":"New daily persistent headache in the paediatric population","volume":"29","author":"Kung","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s10194-017-0818-y","article-title":"Experts\u2019 opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents","volume":"18","author":"Faedda","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3331024221131331","DOI":"10.1177\/03331024221131331","article-title":"Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache","volume":"43","author":"Aguirre","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell. Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3331024231168089","DOI":"10.1177\/03331024231168089","article-title":"New daily persistent headache: A systematic review and meta-analysis","volume":"43","author":"Cheema","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11916-022-01011-3","article-title":"The Enigma of New Daily Persistent Headache: What Solutions for Pediatric Age?","volume":"26","author":"Papetti","year":"2022","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2021.12.008","article-title":"Efficacy and Safety of Repetitive Intravenous Sodium Valproate in Pediatric Patients With Refractory Chronic Headache Disorders: A Retrospective Review","volume":"128","author":"Pavitt","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/head.14360","article-title":"Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study","volume":"62","author":"Szabo","year":"2022","journal-title":"Headache"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2020.09.014","article-title":"Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents","volume":"114","author":"Greene","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Papetti, L., Sforza, G., Tarantino, S., Moavero, R., Ruscitto, C., Ursitti, F., Ferilli, M.A.N., Vigevano, F., and Valeriani, M. (2021). Features and Management of New Daily Persistent Headache in Developmental-Age Patients. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030385"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/head.14117","article-title":"Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review","volume":"61","author":"Srouji","year":"2021","journal-title":"Headache"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0333102420920644","article-title":"Clinic-based characterization of continuous headache in children and adolescents: Comparing youth with chronic migraine to those with new daily persistent headache","volume":"40","author":"Reidy","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s10194-019-1022-z","article-title":"New daily persistent headache: A systematic review on an enigmatic disorder","volume":"20","author":"Yamani","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s10194-018-0835-5","article-title":"Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: A service evaluation","volume":"19","author":"Puledda","year":"2018","journal-title":"J. Headache Pain."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/pmt-2018-0057","article-title":"Current perspectives on the development and treatment of chronic daily headache in children and adolescents","volume":"9","author":"Connelly","year":"2019","journal-title":"Pain. Manag."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1468-2982.2009.01842.x","article-title":"Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache","volume":"29","author":"Grande","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11916-023-01161-y","article-title":"New Daily Persistent Headache (NDPH): Unraveling the Complexities of Diagnosis, Pathophysiology, and Treatment","volume":"27","author":"Sadeghpour","year":"2023","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/08830738211004514","article-title":"New Daily Persistent Headache in a Pediatric Population","volume":"36","author":"Strong","year":"2021","journal-title":"J. Child. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0883073815624761","article-title":"New Daily Persistent Headache Is Most Likely to Begin at the Start of School","volume":"31","author":"Grengs","year":"2016","journal-title":"J. Child. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1442-200X.2009.02804.x","article-title":"Pediatric chronic daily headache associated with school phobia","volume":"51","author":"Fujita","year":"2009","journal-title":"Pediatr. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10194-007-0418-3","article-title":"The differential diagnosis of chronic daily headaches: An algorithm-based approach","volume":"8","author":"Bigal","year":"2007","journal-title":"J. Headache Pain."},{"key":"ref_24","unstructured":"(2018). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1\u2013211."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s10194-023-01639-5","article-title":"Phenotype of new daily persistent headache: Subtypes and comparison to transformed chronic daily headache","volume":"24","author":"Cheema","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3345\/kjp.2015.58.2.73","article-title":"New daily persistent headache with isolated sphenoiditis in children","volume":"58","author":"Lee","year":"2015","journal-title":"Korean J. Pediatr."},{"key":"ref_27","first-page":"411","article-title":"Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches","volume":"1","author":"Vanast","year":"1987","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1526-4610.2006.00722.x","article-title":"Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine","volume":"47","author":"Rozen","year":"2007","journal-title":"Headache"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17562864231213243","DOI":"10.1177\/17562864231213243","article-title":"A secondary daily persistent headache from onset with underlying nutcracker physiology and spinal epidural venous congestion: Case series with lumbar vein embolization as a therapeutic approach","volume":"16","author":"Rozen","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10072-021-05236-9","article-title":"Is new daily persistent headache a fallout of somatization? An observational study","volume":"43","author":"Uniyal","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/head.13207","article-title":"Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups","volume":"58","author":"Rabner","year":"2018","journal-title":"Headache"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1202103","DOI":"10.3389\/fnhum.2023.1202103","article-title":"Multivariate prediction of long COVID headache in adolescents using gray matter structural MRI features","volume":"17","author":"Kim","year":"2023","journal-title":"Front. Hum. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/03331024211045653","article-title":"No structural brain alterations in new daily persistent headache\u2014A cross sectional VBM\/SBM study","volume":"42","author":"Naegel","year":"2022","journal-title":"Cephalalgia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s10194-023-01581-6","article-title":"Brain structure and cortical activity changes of new daily persistent headache: Multimodal evidence from MEG\/sMRI","volume":"24","author":"Qiu","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10194-023-01577-2","article-title":"Mapping the aberrant brain functional connectivity in new daily persistent headache: A resting-state functional magnetic resonance imaging study","volume":"24","author":"Wang","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/0333102415612766","article-title":"New daily persistent headache: A lack of an association with white matter abnormalities on neuroimaging","volume":"36","author":"Rozen","year":"2016","journal-title":"Cephalalgia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3331024221146314","DOI":"10.1177\/03331024221146314","article-title":"Update in the understanding of new daily persistent headache","volume":"43","author":"Peng","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40272-017-0279-4","article-title":"Differences in Pediatric Headache Prescription Patterns by Diagnosis","volume":"20","author":"Rabner","year":"2018","journal-title":"Paediatr. Drugs"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2013.09.008","article-title":"Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders","volume":"50","author":"Gelfand","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0000000000008105","article-title":"Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"key":"ref_41","first-page":"703","article-title":"Headache in Children and Adolescents","volume":"27","author":"Szperka","year":"2021","journal-title":"Continuum"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0000000000000313","article-title":"New Daily Persistent Headache and OnabotulinumtoxinA Therapy","volume":"42","author":"Ali","year":"2019","journal-title":"Clin. Neuropharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Papetti, L., Frattale, I., Ursitti, F., Sforza, G., Monte, G., Ferilli, M.A.N., Tarantino, S., Proietti Checchi, M., and Valeriani, M. (2023). Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051802"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/head.14452","article-title":"Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review","volume":"63","author":"Zorrilla","year":"2023","journal-title":"Headache"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pediatrneurol.2020.09.009","article-title":"Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine","volume":"114","author":"Das","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11940-016-0408-3","article-title":"Update on New Daily Persistent Headache","volume":"18","author":"Nierenburg","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/03331024211044440","article-title":"Time to retire \u2018New daily persistent headache\u2019: Mode of onset of chronic migraine and tension-type headache","volume":"42","author":"Lobo","year":"2022","journal-title":"Cephalalgia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/head.14424","article-title":"Diagnosing new daily persistent headache in children and adolescents: A survey of clinicians","volume":"62","author":"Gelfand","year":"2022","journal-title":"Headache"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/head.14362","article-title":"Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype","volume":"62","author":"Nagaraj","year":"2022","journal-title":"Headache"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/6\/724\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:52:47Z","timestamp":1760107967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/6\/724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["life14060724"],"URL":"https:\/\/doi.org\/10.3390\/life14060724","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}